Skip to main content
. 2022 Jul 5;12:11370. doi: 10.1038/s41598-022-14965-6

Figure 1.

Figure 1

(a,b) Receiver operating characteristic (ROC) curve for assessment of the confidence of T-SUVmax to predict pathological T3 or T4 tumor. (a differentiated type, b undifferentiated type). c ROC curve for assessment of the confidence of T-SUVmax and N-SUVmax to predict pathological lymph-node metastasis.